Soluble biomarkers were increasingly released at the beginning of the infection followed by a decrease during the six months of follow-up on some specific chemokines, pro-inflammatory and regulatory cytokines, and growth factors as: CCL11, CXCL8, CCL3, CCL4, CCL5, IL-6, IFN-g, IL-17, IL-5, FGF-basic, PDGF, VEGF, G-CSF, and GM-CSF. The gene discussed is CSF2; the disease is infection.